Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Jeremy Chataway*, Angelis F De, Peter Connick, RA Parker, Domenico Plantone, Anisha Doshi, Nevin John, Jonathan Stutters, David MacManus, Carrasco F Prados, Frederik Barkhof, Sebastien Ourselin, Marie Braisher, Moira Ross, Gina Cranswick, Sue H. Pavitt, Gavin Giovannoni, Wheeler-Kingshott CA Gandini, Clive Hawkins, Basil SharrackRoger Bastow, Christopher J. Weir, Nigel Stallard, Siddharthan Chandran, Jeremy Chataway*, Wheeler-Kingshott CAM Gandini, Angelis F De, Domenico Plantone, Anisha Doshi, Nevin John, Thomas Williams, Marie Braisher, Tiggy Beyene, Vanessa Bassan, Alvin Zapata, Siddharthan Chandran, Peter Connick, Dawn Lyle, James Cameron, Daisy Mollison, Shuna Colville, Baljean Dhillon, Christopher J. Weir, RA Parker, Moira Ross, Gina Cranswick, Gavin Giovannoni, Sharmilee Gnanapavan, Richard Nicholas, Waqar Rashid, Julia Aram, Helen Ford, James Overell, Carolyn Young, Heinke Arndt, Martin Duddy, Joe Guadagno, Nikolaos Evangelou, Matthew Craner, Jacqueline Palace, Jeremy Hobart, Basil Sharrack, David Paling, Clive Hawkins, Seema Kalra, B McLean, Nigel Stallard, Roger Bastow

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)
Original languageEnglish
Pages (from-to)214-225
Number of pages0
JournalThe Lancet Neurology
Volume19
Issue number3
Early online date22 Jan 2020
DOIs
Publication statusPublished - Mar 2020

Cite this